CV Sciences (CVSI) Operating Margin (2013 - 2026)
CV Sciences (CVSI) reported Operating Margin of 9.95% for Q1 2026, down 1026.0% on a YoY basis from 1.07% in Q1 2025, and down 338.86% sequentially from 2.27% in Q4 2025.
CV Sciences (CVSI) Operating Margin (2013 - 2026) Analysis & Trends
CV Sciences (CVSI) has 14 years of Operating Margin data on file, last reported at 9.95% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin fell 1026.0% year-over-year to 9.95%; the trailing twelve-month figure through Mar 2026 stood at 5.97% (up 421.0% YoY), and the FY2025 full-year result was 3.41%, up 1054.0% from the prior year.
- Operating Margin retreated to 9.95% in Q1 2026, from 2.27% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 138.91% in Q1 2023 to a low of 55.94% in Q2 2022.
- A 5-year average of 10.04% and a median of 14.74% in 2024 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin soared 17298 bps in 2023 and plunged 15440 bps in 2024, its largest moves.
- Tracing CVSI's Operating Margin over 5 years: stood at 54.92% in 2022, then soared by 57 bps to 23.39% in 2023, then rose by 29 bps to 16.63% in 2024, then jumped by 86 bps to 2.27% in 2025, then tumbled by 339 bps to 9.95% in 2026.
- Business Quant data shows CVSI's Operating Margin at 9.95% in Q1 2026, 2.27% in Q4 2025, and 8.45% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | -9.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.95% |
| Dec 31, 2025 | -2.27% |
| Sep 30, 2025 | -8.45% |
| Jun 30, 2025 | -3.62% |
| Mar 31, 2025 | 0.31% |
| Dec 31, 2024 | -16.63% |
| Sep 30, 2024 | -8.82% |
| Jun 30, 2024 | -14.74% |
| Mar 31, 2024 | -15.49% |
| Dec 31, 2023 | -23.39% |
| Sep 30, 2023 | -10.69% |
| Jun 30, 2023 | -27.13% |
| Mar 31, 2023 | 138.91% |
| Dec 31, 2022 | -54.92% |
| Sep 30, 2022 | -23.78% |
| Jun 30, 2022 | -55.94% |
| Mar 31, 2022 | -34.07% |
| Dec 31, 2021 | -177.96% |
| Sep 30, 2021 | -58.35% |
| Jun 30, 2021 | -68.45% |